NCT04381650 2025-12-10A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Completed161 enrolled 44 charts
NCT04065555 2022-07-29Intratumoral Microdosing of TAK-981 in Head and Neck CancerPresage BiosciencesPhase EARLY_PHASE1 Completed12 enrolled